Federated Hermes’s Ocular Therapeutix OCUL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$19 Hold
2
﹤0.01% 2052
2025
Q1
$15 Sell
2
-2
-50% -$15 ﹤0.01% 2045
2024
Q4
$34 Buy
4
+1
+33% +$9 ﹤0.01% 2057
2024
Q3
$26 Buy
3
+2
+200% +$17 ﹤0.01% 2035
2024
Q2
$7 Sell
1
-59
-98% -$413 ﹤0.01% 2009
2024
Q1
$546 Buy
+60
New +$546 ﹤0.01% 1984
2023
Q3
Sell
-2,747
Closed -$14.2K 2168
2023
Q2
$14.2K Buy
2,747
+2,527
+1,149% +$13K ﹤0.01% 1817
2023
Q1
$1.16K Sell
220
-141
-39% -$743 ﹤0.01% 2036
2022
Q4
$1.01K Sell
361
-801,375
-100% -$2.25M ﹤0.01% 2053
2022
Q3
$3.33M Sell
801,736
-390,336
-33% -$1.62M 0.01% 765
2022
Q2
$4.79M Buy
1,192,072
+569,792
+92% +$2.29M 0.01% 691
2022
Q1
$3.08M Buy
+622,280
New +$3.08M 0.01% 904
2021
Q2
Sell
-313,238
Closed -$5.14M 2292
2021
Q1
$5.14M Buy
313,238
+64,327
+26% +$1.06M 0.01% 846
2020
Q4
$5.15M Buy
248,911
+248,702
+118,996% +$5.15M 0.01% 799
2020
Q3
$2K Buy
+209
New +$2K ﹤0.01% 2100
2018
Q2
Sell
-11
Closed -$1K 2259
2018
Q1
$1K Sell
11
-110
-91% -$10K ﹤0.01% 2111
2017
Q4
$1K Hold
121
﹤0.01% 2121
2017
Q3
$1K Sell
121
-143
-54% -$1.18K ﹤0.01% 2094
2017
Q2
$2K Buy
+264
New +$2K ﹤0.01% 2040
2016
Q4
Sell
-261,700
Closed -$1.8M 2145
2016
Q3
$1.8M Sell
261,700
-1,134,587
-81% -$7.8M 0.01% 893
2016
Q2
$6.91M Sell
1,396,287
-250,946
-15% -$1.24M 0.02% 478
2016
Q1
$15.9M Hold
1,647,233
0.05% 312
2015
Q4
$15.4M Sell
1,647,233
-71,247
-4% -$668K 0.05% 332
2015
Q3
$24.2M Buy
1,718,480
+358,780
+26% +$5.04M 0.08% 251
2015
Q2
$28.6M Buy
1,359,700
+1,131,900
+497% +$23.8M 0.09% 249
2015
Q1
$9.56M Sell
227,800
-122,200
-35% -$5.13M 0.03% 469
2014
Q4
$8.23M Hold
350,000
0.03% 492
2014
Q3
$5.24M Buy
+350,000
New +$5.24M 0.02% 625